Çocuklarda Kalp Transplantasyonu

Dipchand, A. I. (2018). Current state of pediatric cardiac transplantation. Annals of Cardiothoracic Surgery, 7(1), 31-55. https://doi.org/10.21037/acs.2018.01.07

Mancini, D., Gibson, G. T., & Rangasamy, S. (2021). Improving survival after heart transplantation despite increasing complexity. European Heart Journal, 42(48), 4944–4946. https://doi.org/10.1093/eurheartj/ehab517

T.C. Sağlık Bakanlığı, 2022. Türkiye'de Çocuk Kalp Nakli İstatistikleri.

Kantrowitz A, Haller JD, Joos H et al. Transplantation of the heart in an infant and an adult. Am J Cardio, 1968;22:782-90.

Parisi F. Advances in pediatric transplantation: Heart and lung. Transplant Proc, 2001;33:1725-6.

Bailey LL, Nehlsen-Cannarella SL, Doroshow RW et al. Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. N Engl J Med, 1986; 315:949-51.

Boucek MM, Edwards LB, Keck Bm et al. The Registry of the Interna-tional Society for Heart and Lung Transplantation: Fifth Official Pediatric Report 2001 to 2002. J Heart Lung Transplant, 2002;21:827-40.

International Society for Heart and Lung Transplantation (ISHLT). (2023). International Thoracic Organ Transplant (TTX) Registry Data Slides. [https://ishlt.org/research-data/registries/ttx-registry]

Kindel, S. J., & Everitt, M. D. (2016). A contemporary review of paediatric heart transplantation and mechanical circulatory support. Cardiology in the Young, 26(5), 851-859. https://doi.org/10.1017/S1047951116000184

İguidbashian J, Yoeli D, Everitt MD, Campbell DN, Mitchell MB, Jaggers J, Stone ML. Pediatric Heart Transplant Waiting List Times in the US During the COVID-19 Pandemic. JAMA Network Open. 2022;5(10). doi:10.1001/jamanetworkopen.2022.34874.

Cascino TM, McCullough JS, Wu X, et al. Comparison of Evaluations for Heart Transplant Before Durable Left Ventricular Assist Device and Subsequent Receipt of Transplant at Transplant vs Nontransplant Centers. JAMA Network Open. 2022;5(11) doi:10.1001/jamanetworkopen.2022.40646.

Özdoğan ME, Erer D, Soncul H ve ark. Çocukluk yaş grubunda yapılan ve yaşayan ilk kalp transplantasyonu. Organ Nakli Kuruluşları Koordinasyon Derneği III. Kongresi, 17-20 Ekim 2002, Adana.

Özer A, Erer D, İriz E, Özdoğan ME. Kalp nakli sonrası Türkiye’de doğum yapıp ve sağlıklı bebek sahibi olan ilk vakamız. Türk Kalp ve Damar Cerrahisi Derneği 15. Kongresi; 2018. Bildiri No: SS-188. (79)

Özdoğan ME, İriz E, Erer D, Kula S, Aslan AT, Ünal Y, et al. Orthotopic heart transplantation in a two-year-old patient with dilated cardiomyopathy. Turkish J Thorac Cardiovasc Surg. 2012;20(4):723–6. doi:10.5606/tgkdc.dergisi.2012.173

Del Rio M, Bailey LL. Heart transplantation for conge- nital heart disease. In Baue AE (ed): Glenn’s Thoracic and Cardiovascular Surgery, 6th ed. volume II. Stamford, Appleton & Lange, 1996;1475-90.

Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: An Overview. Int J Mol Sci. 2021;22(14):7722. doi:10.3390/ijms22147722.

Birla AK, Brimmer S, Short WD, et al. Current state of the art in hypoplastic left heart syndrome. Front Cardiovasc Med. 2022;9:878266. doi:10.3389/fcvm.2022.878266.

Kotani Y, Chetan D, Zhu J, et al. Fontan failure and death in contemporary Fontan circulation: Analysis from the last two decades. Ann Thorac Surg. 2018;105:1240-1247.

Wu Y, Jin X, Zhang Y, et al. Genetic and epigenetic mechanisms in the development of congenital heart diseases. World Jnl Ped Surgery 2021;4:e000196. doi:10.1136/ wjps-2020-000196

Atti V, Narayanan MA, Patel B, et al. A Comprehensive Review of Mechanical Circulatory Support Devices. Heart International. 2022;16(1):37–48. doi:10.17925/HI.2022.16.1.37.

Morrow WR. Cardiomyopathy and heart transplantati- on in children. Curr Opin Cardiol, 2000;15:216-23.

McNamara N, Narroway H, Williams M, et al. Contemporary outcomes of continuous-flow left ventricular assist devices—a systematic review. Ann Cardiothorac Surg. 2021;10(2):186-208. doi:10.21037/acs-2021-cfmcs-35.

Malinow I, Fong DC, Miyamoto M, et al. Pediatric dilated cardiomyopathy: a review of current clinical approaches and pathogenesis. Front Pediatr. 2024;12:1404942. doi:10.3389/fped.2024.1404942.

Huebler M, Schubert S, Lehmkuhl HB, et al. Pediatric heart transplantation: 23-year single-center experience. Eur J Cardiothorac Surg. 2011;39(5) doi:10.1016/j.ejcts.2010.12.067.

Parisi F, Squitieri C, Carotti A et al. Ten-year follow-up after pediatric transplantation. J Heart Lung Transplant, 1999;18:275-7.

Morrow WR, Naftel D, Chinnock R et al. Outcome of listing for heart transplantation in infants younger than six months: Predictors of death and interval to trans- plantation. J Heart Lung Transplant, 1997;16:1255-66.

Nesseler N, Mansour A, Cholley B, et al. Perioperative Management of Heart Transplantation: A Clinical Review. Anesthesiology. 2023;139:493-510. doi:10.1097/ALN.0000000000004627.

Martin RD, Parisi F, Robinson TW, Bailey LL. Anesthetic management of neonatal cardiac transplantation. J Cardiothorac Anesth, 1989;3:465-9.

Ortega R, Connor CW. Intraoperative Management of Patients with Pulmonary Hypertension. Advances in Pulmonary Hypertension. 2013;12(1):18-23. doi:10.21693/1933-088X-12.1.18.

Stark J, De Leval M (ed). Surgery for Congenital Heart Defects. 2nd Edition, W.B. Saunders Company, 1994;665- 81.

Morris, E. A., Parvizi, R., Orzechowski, N. M., Whitfield, M. L., & Pioli, P. A. (2024). Mycophenolate mofetil directly modulates myeloid viability and pro-fibrotic activation of human macrophages. Rheumatology. https://doi.org/10.1093/rheumatology/keae517

Lobo, D. N. (2024). High-dose glucocorticoids: improving outcomes of emergency laparotomy by reducing inflammation. British Journal of Surgery, 111(7), znae153. https://doi.org/10.1093/bjs/znae153

Nourbakhsh, N., Ekberg, J., Skov, K., et al. (2021). Effects of corticosteroid treatment on mycophenolic acid exposure in renal transplant patients—Results from the SAILOR study. Frontiers in Pharmacology, 12, 742444. https://doi.org/10.3389/fphar.2021.742444

Pietra, B. A., & Boucek, M. M. (2000). Immunosuppression for pediatric cardiac transplantation in the modern era. Progress in Pediatric Cardiology, 11, 115-129.

Katz, D. T., Torres, N. S., Chatani, B., et al. (2020). Care of pediatric solid organ transplant recipients: An overview for primary care providers. Pediatrics, 146(6), e20200696. https://doi.org/10.1542/peds.2020-0696

Velleca, A., Shullo, M. A., Dhital, K., et al. (2022). The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. Journal of Heart and Lung Transplantation, 1053-2498. https://doi.org/10.1016/j.healun.2022.10.015

Liversedge, M., Wang, J., Boustany, M., Sharova, A., Downes, K. J., & Otto, W. (2024). Invasive fungal disease in pediatric heart transplant recipients. Journal of the Pediatric Infectious Diseases Society, 13(Suppl_4), 25–26. https://doi.org/10.1093/jpids/piae093.070

Dadwal, S. S., Papanicolaou, G. A., & Boeckh, M. (2023). How I prevent viral reactivation in high-risk patients. Blood, 141(17), 2062–2074. https://doi.org/10.1182/blood.2021014676

Kim, Y. H. (2021). Pediatric heart transplantation: How to manage problems affecting long-term outcomes? Clinical and Experimental Pediatrics, 64(2), 49–59. https://doi.org/10.3345/cep.2019.01417

Kanter KR, Tam VKH, Vincent RN et al. Current results with pediatric heart transplantation. Ann Thorac Surg, 1999;68:527-31.

Shaddy RE, Naftel DC, Kirklin JK et al. Outcome of car- diac trans plantation in children. Survival in a contem- porary multi-institutional experience. Circulation, 1996;94(Suppl II):69-73.

Radley-Smith RC, Yacoub MH. Long-term results of pediatric heart transplantation. J Heart Lung Transplant, 1992;11:277-81.

Hsu DT, Quaegebeur JM, Michler RE et al. Heart transplantation in children with congenital heart disea- se. J Am Coll Cardiol, 1995;26:743-9.

Gajarski RJ, Smith EO, Denfield SW et al. Long-term results of triple-drug-based immunusuppression in nonneonatal pediatric heart transplant recipients. Transplantation, 1998;65:1470-6.

Dellgren G, Koirala B, Sakopoulus A et al. Pediatric heart transplantation: Improving results in high-risk patients. J Thorac Cardiovasc Surg, 2001;121:782-91.

Bauer J, Thul J, Kramer U et al. Heart transplantation in children and infants: short-term outcome and long- term follow-up. Pediatr Transplant, 2001;5:457-62.

Luikart H. Pediatric cardiac transplantation: Management issues. Pediatr Nurs, 2001;16:320-31.

Kounatidis, D., Brozou, V., Anagnostopoulos, D., Pantos, C., Lourbopoulos, A., & Mourouzis, I. (2023). Donor Heart Preservation: Current Knowledge and the New Era of Machine Perfusion. International Journal of Molecular Sciences, 24(23), 16693. https://doi.org/10.3390/ijms242316693.

Amdani, S., Kirklin, J.K., Cantor, R., et al. (2024). Prevalence and Impact of Recurrent Rejection on Pediatric Heart Transplant Recipients: A PHTS Multi-Institutional Analysis. Journal of the American College of Cardiology (JACC), Published online October 02, 2024. https://doi.org/10.1016/j.jacc.2024.08.010.

Bahakel, H., Waghmare, A., & Madan, R. P. (2024). Impact of Respiratory Viral Infections in Transplant Recipients. Journal of the Pediatric Infectious Diseases Society, 13(Supplement_1), S39–S48. https://doi.org/10.1093/jpids/piad094.4o

Sethi GK, Rosado LJ, McCarthy M, Butman SS, Copeland JG. Futility of yearly biopsies in patients undergoing heart transplantation. J Thorac Cardiovasc Surg, 1992;104:90-3.

Glanville AR, Imoto E, Baldwin JC et al. The role of right ventricular biopsy in the late management of heart- lung transplant recipients. J Heart Transplant, 1987;6:357-61.

Schultz, J., & Stehlik, J. (2022). Emergence of Donor-Derived Cell-Free DNA Monitoring For Heart Transplant: Future of Rejection Surveillance. American College of Cardiology, Expert Analysis, May 05, 2022. Retrieved from https://www.acc.org.

Farcas, A. O., Stoica, M. C., Maier, I. M., et al. (2024). Heart Transplant Rejection: From the Endomyocardial Biopsy to Gene Expression Profiling. Biomedicines, 12(8), 1926. https://doi.org/10.3390/biomedicines12081926.

Das, B. B., Deshpande, S., & Hussain, T. (2022). Multimodality Imaging to Detect Rejection, and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients—An Illustrative Review. Transplantology, 3(3), 241–256. https://doi.org/10.3390/transplantology3030025.

de Koning, C., Prockop, S., van Roessel, I., et al. (2021). CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host disease: a dual-center validation. Blood, 137(6), 848–855. https://doi.org/10.1182/blood.2020007905.

Green, D. J., Duong, S. Q., Burckart, G. J., et al. (2018). Association Between Thiopurine S-Methyltransferase (TPMT) Genetic Variants and Infection in Pediatric Heart Transplant Recipients Treated With Azathioprine: A Multi-Institutional Analysis. Journal of Pediatric Pharmacology and Therapeutics: JPPT, 23(2), 131-138. https://doi.org/10.5863/1551-6776-23.2.131.

van Saet, A., Zeilmaker-Roest, G. A., Stolker, R. J., Bogers, A. J. J. C., & Tibboel, D. (2021). Methylprednisolone in Pediatric Cardiac Surgery: Is There Enough Evidence? Frontiers in Cardiovascular Medicine, 8, Article 730157. https://doi.org/10.3389/fcvm.2021.730157.

Spinner, J. A., & Denfield, S. W. (2022). Immunosuppressant Drugs and Their Effects on Children Undergoing Solid Organ Transplant. Pediatrics Review, 43(2), 71-86. https://doi.org/10.1542/pir.2020-000620.

Nguyen, C., & Shapiro, R. (2014). New immunosuppressive agents in pediatric transplantation. Clinics, 69(S1), 8-16. https://doi.org/10.6061/clinics/2014(Sup01)02.

Masarone, D., Kittleson, M., Gravino, R., Valente, F., Petraio, A., & Pacileo, G. (2021). The Role of Echocardiography in the Management of Heart Transplant Recipients. Diagnostics, 11(12), 2338. https://doi.org/10.3390/diagnostics11122338.

Gupta, D., & Clifford, S. A. (2023). Use of REGEN-COV in children after heart transplantation for treatment and post-exposure prophylaxis of COVID-19. Cardiology in the Young, 33(3), 496-497. https://doi.org/10.1017/S1047951122002190.

Özdoğan E, Banner N, Fitzgerald M et al. Factors influencing the development of hypertension after heart transplantation. J Heart Transplant, 1990;9:548-53.

Baum ME, Chinnock RE, Ashwal S et al. Growth and neurodevelopmental outcome of infants undergoing heart transplantation. J Heart Lung Transplant, 1993;12:211-7.

Amengual, J. E., & Pro, B. (2023). How I treat posttransplant lymphoproliferative disorder. Blood, 142(17), 1426–1437. https://doi.org/10.1182/blood.2023020075.

Jimenez Ubieto, A., Gil Manso, R., Gil Alós, D., et al. (2023). Incidence, Management and Outcome of Post-Transplant Lymphoproliferative Disease after 5797 Solid-Organ Transplants over a 30-Year Period in a Single Hospital. Blood, 142(Supplement 1), 4490. https://doi.org/10.1182/blood-2023-189478.

Rao, P. S. (2023). Advances in the Diagnosis and Management of Congenital Heart Disease in Children. Children, 10(4), 753. https://doi.org/10.3390/children10040753.

Townsend, M., Khoury, M., Koehl, D., et al. (2024). Uncertain Benefit of Statins in Pediatric Heart Transplant Recipients: A PHTS Analysis. The Journal of Heart and Lung Transplantation, 43(5), 703-713. https://doi.org/10.1016/j.healun.2023.11.021.

Nesseler, N., Mansour, A., & Cholley, B., et al. (2023). Perioperative management of heart transplantation: A clinical review. Anesthesiology, 139, 493–510. https://doi.org/10.1097/ALN.0000000000004627

De Broux E, Huot CH, Chartrand S, Chartrand C. Growth after pediatric heart transplantation. Transplant Proc, 2001;33:1735-7.

Nixon PA, Morris KA. Quality of life in pediatric heart, heart-lung, and lung transplant recipients. Int J Sports Med, 2000;21(Suppl 2):109-12.

Cousino, M. K., Schumacher, K. R., & Rea, K. E., et al. (2018). Psychosocial functioning in pediatric heart transplant recipients and their families. Pediatric Transplantation, 22(2), e13110. https://doi.org/10.1111/petr.13110

Tadros, H. J., Gupta, D., Rawlinson, A., et al. (2020). Assessing the psychosocial impact of pediatric heart transplantation on family functioning: A cross-sectional study identifying variables associated with poor psychosocial outcomes. Pediatrics, 146(1_MeetingAbstract), 605–606. https://doi.org/10.1542/peds.146.1MA7.605

Stanford, N. T., McAllister, J., Gibbons, M., et al. (2022). Quality of life and lifetime achievement in adult survivors of pediatric heart transplant. Pediatric Transplantation, 26(7), e14370. https://doi.org/10.1111/petr.14370